VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.-Reference-Cited by-同舟云学术

VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.

Published:2023-06 Issue:S2 Volume:41 Page:151-152
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Sarkozy C.¹,Thieblemont C.²,Oberic L.³,Moreau A.⁴,Bouabdallah K.⁵,Damaj G.⁶,Gastine T.⁷,Ribrag V.⁸,Casasnovas O.⁹,Haioun C.¹⁰,Houot R.¹¹,Jardin F.¹²,Van Den Neste E.¹³,Cheminant M.¹⁴,Morschhauser F.¹⁵,Callana M.⁹,Ghesquieres H.¹⁶,Gressin R.¹⁷,Hermine O.¹⁴,Le Gouill S.¹

Affiliation:

1. Institut Curie Saint Cloud France

2. APHP Saint Louis Paris France

3. Oncopole Hematology Toulouse France

4. CHU Nantes Nantes France

5. CHU Bordeaux Hematology Bordeaux France

6. CHU Caen Hematology Caen France

7. CHU Nantes Hematology Nantes France

8. IGR Hematology Villejuif France

9. CHU Dijon Hematology Dijon France

10. APHP Henri Mondor Créteil France

11. CHU Rennes Hematology Rennes France

12. Centre Henri Becquerel Rouen France

13. CHU Louvain Belgium

14. APHP Necker paris France

15. CHU Lille Lille France

16. CHU Lyon Sud Pierre Bénite France

17. CHU Grenoble Grenoble France

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3163_100

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma;Blood;2024-07-18